22MarrKA,BalajeeSA,McLaughlinL,etal.Detectionof
galactomannanantigenemiabyenzymeimmunoassayforthediagnosisofinvasiveaspergillosis:variablesthataffectperfor-mance.JInfectDis2004;190:641Á649.
23GraybillJR,KasterS,DrutzD.Treatmentofexperimental
murineaspergillosiswithBAYn7133.JInfecDis1983;148:898Á906.
24KirkpatrickWR,PereaS,CocoBJ,PattersonTF.Ef cacyof
caspofunginaloneandincombinationwithvoriconazoleinaGuineapigmodelofinvasiveaspergillosis.AntimicrobAgentsChemother2002;46:2564Á2568.
25BowmanJC,AbruzzoGK,AndersonJW,etal.Quantitative
OCRassaytomeasureAspergillusfumigatusburdeninamurinemodelofdisseminatedaspergillosis:Demonstrationofef cacyofcaspofunginacetate.AntimicrobAgentsChemother2001;45:3474Á3481.
26Loef erJ,KloepferK,HebartH,etal.Polymerasechainreaction
detectionofaspergillusDNAinexperimentalmodelsofinvasiveaspergillosis.JInfectDis2002;185:1203Á1206.
27OdabasiZ,MattiuzziG,EsteyE,etal.Beta-D-glucanasa
diagnosticadjunctforinvasivefungalinfections:validation,cutoff–2005ISHAM,MedicalMycology,43,S115ÁS119
development,andperformanceinpatientswithacutemyelogen-ousleukemiaandmyelodysplasticsyndrome.ClinInfectDis2004;39:199Á205.28WalshTJ,GarrettK,FeuersteinE,etal.Therapeuticmonitoringofexperimentalinvasivepulmonaryaspergillosisbyultrafastcomputerizedtomography,anovel,noninvasivemethodformeasuringresponsestoantifungaltherapy.AntimicrobAgentsChemother1995;39:1065Á1069.29SheppardDC,RiegG,ChiangLY,etal.Novelinhalationalmurinemodelofinvasivepulmonaryaspergillosis.AntimicrobAgentsChemother2004;48:1908Á1911.30McMurrayDN.Diseasemodel:pulmonarytuberculosis.TrendsMolMed2001;7:135Á137.31KirkpatrickWR,CocoBJ,PattersonTF.Anewanimalmodelofinvasivepulmonaryaspergillosis(IPA)usinglargescaleinhala-tionalchallenge.In:Abstractsofthe44thInterscienceConferenceonAntimicrobialAgentsandChemotherapy,Washington,DC,30OctoberÁ2November;2004.32ZaasA,SteinbachW,BurchL,PerfectJ,SchwartzD.Suscept-ibilitytoAspergillusfumigatus:RoleofHostGeneticBack-ground.In:Abstractsofthe7thAnnualEuropeanConferenceonFungalGenetics,CopenhagenDenmark;2004.